CCNA2 was positively correlated with expressions of CD274, CTLA4, HAVCR2, LAG3, PDCD1, and TIGIT in most cancer types, which indicated the CCNA2 expression may act as a marker after immunotherapy. Here, CTLA4 is linked to cancer.